InvestorsHub Logo
icon url

MrDanMan

11/04/13 12:14 PM

#2896 RE: Juliet November #2895

Prior mis-management did a lot of harm to Advaxis. The company is slowly getting on the right path once again though and market sentiment will soon follow. News of Orphan Drug Designation for head and neck is another advancement.